Submissions from 2022
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS), Jonathan I. Silverberg, Eric L. Simpson, Brian M. Calimlim, Leighann Litcher-Kelly, Xiaoran Li, Xiaowu Sun, and Yael A. Leshem
Predictors of chronic COVID-19 symptoms in a community-based cohort of adults, Jonathan I. Silverberg, Israel Zyskind, Hiam Naiditch, Jason Zimmerman, Aaron E. Glatt, Abraham Pinter, Elitza S. Theel, Michael J. Joyner, D Ashley Hill, Miriam R. Lieberman, Elliot Bigajer, Daniel Stok, Elliot Frank, and Avi Z. Rosenberg
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes, Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, and Jonathan I. Silverberg
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes, Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, and Jonathan I. Silverberg
Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials, Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg, Kristian Reich, Richard B. Warren, Delphine Staumont-Sallé, Giampiero Girolomoni, Kim Papp, Marjolein de Bruin-Weller, Jacob P. Thyssen, Rebecca Zachariae, Christiana K. Olsen, and Andreas Wollenberg
Patient-oriented measures for phase 3 studies of tralokinumab for treatment of atopic dermatitis (ECZTRA 1, 2 and 3), Eric L. Simpson, Andreas Wollenberg, Weily Soong, Louise Abildgaard Steffensen, Azra Kurbasic, Shannon Schneider, John Zoidis, and Jonathan I. Silverberg
Olfactory dysfunction in children and adults post-COVID-19 infection in Brooklyn, New York, Tamar A. Smith-Norowitz, Jonathan I. Silverberg, Esther M. Norowitz, Jeffrey Loeffler, Margaret R. Hammerschlag, and Stephan Kohlhoff
Acoustic Shockwave Therapy as an Adjunct to Picosecond Laser for Multicolored Tattoo Removal, Pooja Sodha, Jordan V. Wang, and Paul M. Friedman
High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents, S Ständer, N Bhatia, M J. Gooderham, J I. Silverberg, J P. Thyssen, P Biswas, M DiBonaventura, W Romero, and S A. Farooqui
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial, Sonja Ständer, Shawn G. Kwatra, Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Gil Yosipovitch, Fan Zhang, Michael C. Cameron, Ricardo Rojo Cella, Hernan Valdez, Marco DiBonaventura, and Claire Feeney
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial, Linda Stein Gold, Kim Papp, David Pariser, Lawrence Green, Neal Bhatia, Howard Sofen, Lorne Albrecht, Melinda Gooderham, Mindy Chen, Maria Paris, Yao Wang, and Kristina Callis Duffin
Improving dermatology residency program website transparency in the era of preference signaling., Surya A Veerabagu, Justin Jia, Zizi Yu, David Gao, Jared S Kahn, Jordan Tanner, Nicole M Burkemper, Adam J. Friedman, Jennifer T Huang, Kristin M Nord, David Rosmarin, and Andrea T Murina
The National Mentorship Match Algorithm: A new approach to filling mentorship gaps, Surya A. Veerabagu, Rebecca Trinklein, Jeremy R. Etzkorn, Thomas H. Leung, Christopher J. Miller, Ilana S. Rosman, and Adam J. Friedman
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets, R B. Warren, B Strober, J I. Silverberg, E Guttman, P Andres, J Felding, D Tutkunkardas, K Kjøller, M O. Sommer, and L E. French
Occupational Contact Dermatitis in Dental Personnel: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001 to 2018, Erin M. Warshaw, Jenna L. Ruggiero, Amber R. Atwater, Joel G. DeKoven, Kathryn A. Zug, Margo J. Reeder, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Howard I. Maibach, Marie-Claude Houle, Donald V. Belsito, Joseph F. Fowler, Cory A. Dunnick, Vincent A. DeLeo, Denis Sasseville, and Anthony F. Fransway
Patch Test Reactions Associated With Topical Medications: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001-2018), Erin M. Warshaw, Rob L. Shaver, Joel G. DeKoven, James S. Taylor, Amber R. Atwater, Anthony F. Fransway, Howard I. Maibach, Donald V. Belsito, Jonathan I. Silverberg, Marie-Claude Houle, Margo J. Reeder, Kathryn A. Zug, Joseph F. Fowler, Denis Sasseville, Melanie D. Pratt, Cory A. Dunnick, and Vincent A. DeLeo
Co-reactivity of glucosides: Retrospective analysis of North American Contact Dermatitis Group Data 2019-2020, Erin M. Warshaw, Michelle Xiong, Joel G. DeKoven, James S. Taylor, Donald V. Belsito, Margo J. Reeder, Brandon L. Adler, Melanie D. Pratt, Amber R. Atwater, Howard I. Maibach, Jonathan I. Silverberg, JiaDe Yu, Nina Botto, Joseph F. Fowler, Marie-Claude Houle, Christen M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
A review of the microbiome in skin aging and the effect of a topical prebiotic containing thermal spring water, Heather Woolery-Lloyd, Anneke Andriessen, Doris Day, Noelani Gonzalez, Lawrence Green, Elizabeth Grice, and Michelle Henry
Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta-Analysis of Benefits and Harms, Juan José Yepes-Nuñez, Gordon H. Guyatt, Luis Guillermo Gómez-Escobar, Lucia C. Pérez-Herrera, Alexandro Chu, Renata Ceccaci, Ana Sofía Acosta-Madiedo, Aaron Wen, Sergio Moreno-López, Margaret MacDonald, Mónica Barrios, Xiajing Chu, Nazmul Islam, Ya Gao, Melanie M. Wong, Rachel Couban, Elizabeth Garcia, Edgardo Chapman, Paul Oykhman, Lina Chen, Tonya Winders, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim BscPhm, Jennifer LeBovidge, Mary Laura Lind, and Peter Lio
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase 3 trials, Gil Yosipovitch, Kim Papp, Seth Forman, George Han, Jill Waibel, Maria J. Rueda, Luna Sun, Yun-Fei Chen, Orin Goldblum, Evangeline Pierce, and Jonathan I. Silverberg
Association between atopic dermatitis and hypertension: a systematic review and meta-analysis, M Yousaf, M Ayasse, A Ahmed, E C. Gwillim, S R. Janmohamed, A Yousaf, K R. Patel, J P. Thyssen, and J I. Silverberg
Submissions from 2021
Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus, K. Abuabara, S. G. Nicholls, S. M. Langan, E. Guttman-Yassky, N. J. Reynolds, A. S. Paller, S. J. Brown, Tove Agner, Valeria Aoki, Martine Bagot, Sebastien Barbarot, Lisa Beck, Thomas Bieber, Robert Bissonnette, Andrew Blauvelt, Patrick M. Brunner, David E. Cohen, Michael J. Cork, Anna D. Benedetto, Mette Deleuran, Sandipan Dhar, Ncoza Dlova, Aaron M. Drucker, Lawrence Eichenfield, James T. Elder, Kilian Eyerich, Carsten Flohr, Carlo Gelmetti, Giampiero Girolomoni, Melinda J. Gooderham, Emma Guttman, and Jon M. Hanifin
Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland, J. A. Adalsteinsson, E. Olafsdottir, D. Ratner, R. Waldman, H. Feng, J. Ungar, J. I. Silverberg, A. K. Kristjansson, J. G. Jonasson, and L. Tryggvadottir
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland, Jonas A. Adalsteinsson, Sonal Muzumdar, Reid Waldman, Chaoran Hu, Rong Wu, Désirée Ratner, Hao Feng, Jonathan Ungar, Jonathan I. Silverberg, Gudridur H. Olafsdottir, Arni Kjalar Kristjansson, Laufey Tryggvadottir, and Jon Gunnlaugur Jonasson
Anti–tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study, Jonas A. Adalsteinsson, Sonal Muzumdar, Reid Waldman, Chaoran Hu, Rong Wu, Désirée Ratner, Jonathan Ungar, Jonathan I. Silverberg, Gudridur H. Olafsdottir, Arni Kjalar Kristjansson, Laufey Tryggvadottir, and Jon Gunnlaugur Jonasson
Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland, Jonas A. Adalsteinsson, Sonal Muzumdar, Reid Waldman, Rong Wu, Désirée Ratner, Hao Feng, Jonathan Ungar, Jonathan I. Silverberg, Gudridur H. Olafsdottir, Arni Kjalar Kristjansson, Laufey Tryggvadottir, and Jon Gunnlaugur Jonasson
An Updated Therapeutic Strategy for Chronic Idiopathic Urticaria., Nagasai C. Adusumilli and Adam J. Friedman
Leveraging Virtual Boot Camp to Alleviate First Year Dermatology Resident Anxiety., Nagasai C. Adusumilli, Kayleigh Hausmann, Adam J. Friedman, and Mary Maiberger
Dermatology applicant perspectives of a virtual visiting rotation in the era of COVID-19., Nagasai C. Adusumilli, Jessica Kalen, Kayleigh Hausmann, and Adam J. Friedman
Curcumin nanoparticles as a photoprotective adjuvant., Nagasai C. Adusumilli, Breanne Mordorski, Joshua Nosanchuk, Joel M Friedman, and Adam J. Friedman
Leveraging virtual boot camp to alleviate first year dermatology resident anxiety, Nagasai Adusumilli, Kayleigh Hausmann, Adam J. Friedman, and Mary Maiberger
Curcumin nanoparticles as a photoprotective adjuvant, Nagasai Adusumilli, B. Mordorski, J. Nosanchuk, JM Friedman, and Adam J. Friedman
P38 kinases in cutaneous melanoma: Insights from in vitro studies and database mining, Nagasai Adusumilli, C. Wei, A. Kiss, J. Weiner, A. Yende, Adam Friedman, and T. Efimova
Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018., Amber Reck Atwater, Raina Bembry, Beiyu Liu, Erin M Warshaw, Joel G DeKoven, Jonathan I. Silverberg, James S Taylor, Kathryn A Zug, Marie-Claude Houle, Donald V Belsito, Howard I Maibach, Margo J Reeder, Denis Sasseville, Cory Dunnick, Joseph F Fowler, Melanie D Pratt, and Vincent A DeLeo
Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016, Amber Reck Atwater, Amy J. Petty, Beiyu Liu, Cynthia L. Green, Jonathan I. Silverberg, Joel G. DeKoven, Donald V. Belsito, Margo J. Reeder, Denis Sasseville, James S. Taylor, Howard I. Maibach, Matthew J. Zirwas, James G. Marks, Kathryn A. Zug, Joseph F. Fowler, Melanie D. Pratt, Vincent A. DeLeo, and Erin M. Warshaw
Vaccines do not cause atopic dermatitis: A systematic review and meta-analysis, Marissa Ayasse, Adnan Ahmed, Catherine McCullum, Maria L. Espinosa, Amy S. Paller, and Jonathan I. Silverberg
A case report of uveitis secondary to dupilumab treatment for atopic dermatitis, Marissa Ayasse, Benjamin Lockshin, Brian K. Do, Rachel Kaiser, and Jonathan I. Silverberg
Abrocitinib versus placebo or dupilumab for atopic dermatitis, Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, Carle Paul, Andrew E. Pink, Yoko Kataoka, Chia Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, and Hernan Valdez
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial, Andrew Blauvelt, Jonathan I. Silverberg, Charles W. Lynde, Thomas Bieber, Samantha Eisman, Jacek Zdybski, Walter Gubelin, Eric L. Simpson, Fernando Valenzuela, Paulo Ricardo Criado, Mark G. Lebwohl, Claire Feeney, Tahira Khan, Pinaki Biswas, Marco DiBonaventura, Hernan Valdez, Michael C. Cameron, and Ricardo Rojo
Burden and characteristics of skin pain among children with atopic dermatitis., Brian T. Cheng, Amy S. Paller, James W. Griffith, Jonathan I. Silverberg, and Anna B. Fishbein
Patient satisfaction scores in adults with psoriasis, Brian T. Cheng and Jonathan I. Silverberg
Association of pediatric atopic dermatitis and psoriasis with school absenteeism and parental work absenteeism: A cross-sectional United States population-based study., Brian T. Cheng and Jonathan I. Silverberg
Association of Childhood Atopic Dermatitis with Atopic and Nonatopic Multimorbidity, Brian T. Cheng, Nanette B. Silverberg, and Jonathan I. Silverberg
Clinical phenotyping of atopic dermatitis using combined itch and lesional severity: A prospective observational study, Raj Chovatiya, Donald Lei, Adnan Ahmed, Rajeev Chavda, Sylvie Gabriel, and Jonathan I. Silverberg
"Millennial Botulinum Toxin": A Retrospective Age-Matched Cohort Study With OnabotulinumtoxinA., Kelly Chung, Nicole Orme, and Noëlle Sherber
Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program., Joel L Cohen, Lawrence J. Green, Kenneth R Beer, Yan Liu, and Conor J Gallagher
Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate, Caroline Barcelos Costa-Orlandi, Luis R Martinez, Níura Madalena Bila, Joel M Friedman, Adam J. Friedman, Maria José S Mendes-Giannini, and Joshua D Nosanchuk
Interventions to improve primary care provider management of atopic dermatitis: A systematic review, Emily A. Croce, Fabiana C.P.S. Lopes, Jennifer Ruth, and Jonathan I. Silverberg
Occupational contact dermatitis: Retrospective analysis of North American Contact Dermatitis Group Data, 2001 to 2016., Joel G DeKoven, Benjamin M DeKoven, Erin M Warshaw, C G T Mathias, James S Taylor, Denis Sasseville, Donald V Belsito, Joseph F Fowler, Melanie D Pratt, Kathryn A Zug, Howard I Maibach, Vincent A DeLeo, Jonathan I. Silverberg, Amber R Atwater, Margo J Reeder, and D Linn Holness
North American Contact Dermatitis Group Patch Test Results: 2017-2018, Joel G. DeKoven, Jonathan I. Silverberg, Erin M. Warshaw, Amber R. Atwater, Margo J. Reeder, Denis Sasseville, James S. Taylor, Kathryn A. Zug, Donald V. Belsito, Howard I. Maibach, Melanie D. Pratt, Mathias Cgt, Vincent A. DeLeo, and Joseph F. Fowler
Effects of dupilumab treatment on patch test reactions: A retrospective evaluation, Linde E.M. de Wijs, José D. van der Waa, Tamar Nijsten, Jonathan I. Silverberg, Amalia C.M. Kunkeler, and Dirk J. Hijnen
Prediction of histologic grade and type of small (< 4 cm) papillary renal cell carcinomas using texture and neural network analysis: a feasibility study., Shawn Haji-Momenian, RyeAnne Ricker, Zirong Chen, Margaret Houser, Nagasai Adusumilli, Myung Yang, Antoun Toubaji, and Murray Loew
A real-world study of the longitudinal course of itch severity and frequency in adults with atopic dermatitis., Mindy R Hong, Donald Lei, Muhammad Yousaf, Rajeev Chavda, Sylvie Gabriel, Sherief R Janmohamed, and Jonathan I. Silverberg
Increasing rates of influenza vaccination were associated with lower asthma prevalence in United States children, Alexander Hou and Jonathan I. Silverberg
Secular trends of atopic dermatitis and its comorbidities in United States children between 1997 and 2018, Alexander Hou and Jonathan I. Silverberg
Predictors and age-dependent pattern of psychologic problems in childhood atopic dermatitis., Alexander Hou and Jonathan I. Silverberg
Temporal trends of birthweight are not driving trends of atopic dermatitis prevalence in United States children., Alexander Hou and Jonathan I. Silverberg
TH2 sensitization in the skin-gut-brain axis: How early-life Th2-mediated inflammation may negatively perpetuate developmental and psychologic abnormalities, La Donya Jackson-Cowan, Emily F. Cole, Jack L. Arbiser, Jonathan I. Silverberg, and Leslie P. Lawley
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies., Brian S Kim, Jonathan I. Silverberg, Sonja Ständer, Gil Yosipovitch, Eric L Simpson, Marco DiBonaventura, Urs Kerkmann, Saleem A Farooqui, Pinaki Biswas, Hernan Valdez, and Michael C Cameron
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials., Brett King, Catherine Maari, Edward Lain, Jonathan I. Silverberg, Maher Issa, Katrin Holzwarth, Dennis Brinker, Tracy Cardillo, Fabio P Nunes, and Eric L Simpson
Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysis, Mette Hjorslev Knudgaard, Thomas Holger Andreasen, Nanna Ravnborg, Thomas Bieber, Jonathan I. Silverberg, Alexander Egeberg, Anne Sofie Halling, and Jacob P. Thyssen
The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review., Bethany Kotlar, Emily Gerson, Sophia Petrillo, Ana Langer, and Henning Tiemeier
Association between atopic dermatitis and headaches throughout childhood and adolescence—A longitudinal birth cohort study, Jaya Manjunath and Jonathan I. Silverberg
Association of sleep disturbances with geriatric age in atopic dermatitis patients, Jaya Manjunath and Jonathan I. Silverberg
Association of atopic dermatitis with poor school behaviors in US children and adolescents., Jaya Manjunath, Nanette B Silverberg, and Jonathan I. Silverberg
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database, Kristin J. Meyers, Jonathan I. Silverberg, Maria Jose Rueda, Robert Goodloe, Evangeline J. Pierce, Walter Deberdt, and Dennis R. Brinker
Management of atopic dermatitis in the inpatient setting, Shanthi Narla and Jonathan I. Silverberg
The inpatient burden of pyoderma gangrenosum and associated comorbidities in children in the United States., Shanthi Narla and Jonathan I. Silverberg
Management of inadequate response and adverse effects to dupilumab in atopic dermatitis, Shanthi Narla, Jonathan I. Silverberg, and Eric L. Simpson
SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study, C. Nguyen, K. Yale, F. Casale, A. Ghigi, K. Zheng, J. I. Silverberg, and N. A. Mesinkovska
Considerations in association studies in dermatoepidemiology, T. Nijsten, J. Silverberg, P. Gisondi, C. Vestergaard, L. Hollestein, and M. Wakkee
A glossary of pandemic-related terms., Benjamin B Norton, David M Morens, and Scott A. Norton
Atopic dermatitis is not associated with SARS-CoV-2 outcomes., Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, Gabrielle Schwartzman, Brittany Lane, and Jonathan I. Silverberg
Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis, Nanna Ravnborg, Danni Ambikaibalan, Gaurav Agnihotri, Shmuel Price, Supriya Rastogi, Kevin R. Patel, Vivek Singam, Yuki Andersen, Anne Sofie Halling, Jonathan I. Silverberg, Alexander Egeberg, and Jacob P. Thyssen
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial, Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin-Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Thomas Werfel, Jiewei Zeng, Xiaohong Huang, Xiaofei Hu, Barbara A. Hendrickson, Barry Ladizinski, Alvina D. Chu, and Jonathan I. Silverberg
COVID-19-The American Perspective., Karl Saardi and Vesna Petronic-Rosic
Sunscreens: UV filters to protect us: Part 1: Changing regulations and choices for optimal sun protection., Nina Sabzevari, Sultan Qiblawi, Scott A. Norton, and David Fivenson
Mapping routine measles vaccination in low- and middle-income countries, Alyssa N. Sbarra, Sam Rolfe, Jason Q. Nguyen, Lucas Earl, Natalie C. Galles, Ashley Marks, Kaja M. Abbas, Mohsen Abbasi-Kangevari, Hedayat Abbastabar, Foad Abd-Allah, Ahmed Abdelalim, Mohammad Abdollahi, Kedir Hussein Abegaz, Hailemariam Abiy Alemu Abiy, Hassan Abolhassani, Lucas Guimarães Abreu, Michael R.M. Abrigo, Abdelrahman I. Abushouk, Manfred Mario Kokou Accrombessi, Maryam Adabi, Oladimeji M. Adebayo, Victor Adekanmbi, Olatunji O. Adetokunboh, Davoud Adham, Mohsen Afarideh, Mohammad Aghaali, Tauseef Ahmad, Raman Ahmadi, Keivan Ahmadi, Muktar Beshir Ahmed, Fahad Mashhour Alanezi, and Turki M. Alanzi
Incidence of Venous Thromboembolism in Patients with Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases, Maria C. Schneeweiss, Seoyoung C. Kim, Richard Wyss, Yinzhu Jin, Kristyn Chin, Joseph F. Merola, Arash Mostaghimi, Jonathan I. Silverberg, and Sebastian Schneeweiss
Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis., Gabrielle Schwartzman, Donald Lei, Muhammad Yousaf, Sherief R Janmohamed, Paras P Vakharia, Rishi Chopra, Rajeev Chavda, Sylvie Gabriel, Kevin R Patel, Vivek Singam, Robert Kantor, Derek Y Hsu, and Jonathan I. Silverberg
Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey, Yevgeniy R. Semenov, Christina M. Herbosa, Andrew T. Rogers, Amy Huang, Shawn G. Kwatra, Bernard Cohen, Milan J. Anadkat, and Jonathan I. Silverberg
The administrative burden of prescribing and treating with isotretinoin., Nidhi Shah, Elizabeth Smith, Jessica Czermak, Meredith Ferris, and Anna Yasmine Kirkorian
Geographic variation of iPLEDGE-participating pharmacies across major metropolitan cities in the United States., Nidhi Shah, Michelle Truong, Shama Antala, and A Yasmine Kirkorian
Association of atopic dermatitis and autoimmune comorbidities: is it real?, J. I. Silverberg
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study, J. I. Silverberg, A. Pinter, A. Alavi, C. Lynde, J. D. Bouaziz, A. Wollenberg, D. F. Murrell, S. Alpizar, V. Laquer, K. Chaouche, F. Ahmad, J. M. Armstrong, and C. Piketty
Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis, J. I. Silverberg, J. P. Thyssen, K. Fahrbach, K. Mickle, J. C. Cappelleri, W. Romero, M. C. Cameron, D. E. Myers, C. Clibborn, and M. DiBonaventura
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial*, J. I. Silverberg, D. Toth, T. Bieber, A. F. Alexis, B. E. Elewski, A. E. Pink, D. Hijnen, T. N. Jensen, B. Bang, C. K. Olsen, A. Kurbasic, and S. Weidinger
Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study, Jonathan I. Silverberg, Sebastien Barbarot, Abhijit Gadkari, Eric L. Simpson, Stephan Weidinger, Paola Mina-Osorio, Ana B. Rossi, Lysel Brignoli, Grece Saba, Isabelle Guillemin, Miriam C. Fenton, Sebastien Auziere, and Laurent Eckert
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized study, Jonathan I. Silverberg, Emma Guttman-Yassky, Melinda Gooderham, Margitta Worm, Stephanie Rippon, Sean O'Quinn, René van der Merwe, Nana Kragh, Azra Kurbasic, and Andreas Wollenberg
Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016., Jonathan I. Silverberg, Alexander Hou, Erin M Warshaw, Joel G DeKoven, Howard I Maibach, Donald V Belsito, James S Taylor, Kathryn A Zug, Denis Sasseville, Anthony F Fransway, Vincent A DeLeo, Melanie D Pratt, Margo J Reeder, Joseph F Fowler, Matthew J Zirwas, James G Marks, and Amber R Atwater
Age-related differences in patch testing results among children: Analysis of North American Contact Dermatitis Group Data, 2001-2018, Jonathan I. Silverberg, Alexander Hou, Erin M. Warshaw, Joel G. DeKoven, Howard I. Maibach, Donald V. Belsito, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Cory A. Dunnick, Marie Claude Houle, Amber R. Atwater, Margo J. Reeder, Vincent A. DeLeo, Melanie D. Pratt, Joseph F. Fowler, Matthew J. Zirwas, and James G. Marks
Reliability and meaningful change of the Patient-Reported Outcomes Measurement Information System, Jonathan I. Silverberg, J-S Lai, and D Cella
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials., Jonathan I. Silverberg, Eric L Simpson, Emma Guttman-Yassky, Michael J Cork, Marjolein de Bruin-Weller, Gil Yosipovitch, Laurent Eckert, Zhen Chen, Marius Ardeleanu, Brad Shumel, Thomas Hultsch, Ana B Rossi, Jennifer D Hamilton, Jamie M Orengo, Marcella Ruddy, Neil M H Graham, Gianluca Pirozzi, and Abhijit Gadkari
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials., Jonathan I. Silverberg, Eric L Simpson, Andreas Wollenberg, Robert Bissonnette, Kenji Kabashima, Amy M DeLozier, Luna Sun, Tracy Cardillo, Fabio P Nunes, and Kristian Reich
Reply to “Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A 2-year case series of patient-reported outcomes”, Jonathan I. Silverberg, Jacob P. Thyssen, Emma Guttman-Yassky, and Amy S. Paller
Association of varying clinical manifestations and positive anti-SARS-CoV-2 IgG antibodies: a cross-sectional observational study., Jonathan I. Silverberg, Israel Zyskind, Hiam Naiditch, Jason Zimmerman, Aaron E Glatt, Abraham Pinter, Elitza S Theel, Michael J Joyner, D Ashley Hill, Miriam R Lieberman, Elliot Bigajer, Daniel Stok, Elliot Frank, and Avi Z Rosenberg
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5), Eric L. Simpson, Seth Forman, Jonathan I. Silverberg, Matthew Zirwas, Emanual Maverakis, George Han, Emma Guttman-Yassky, Daniel Marnell, Robert Bissonnette, Jill Waibel, Fabio P. Nunes, Amy M. DeLozier, Robinette Angle, Margaret Gamalo, Katrin Holzwarth, Orin Goldblum, Jinglin Zhong, Jonathan Janes, and Kim Papp
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin L. Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Min Zhang, Saleem A. Farooqui, William Romero, Andrew J. Thorpe, Ricardo Rojo, and Susan Johnson
Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease., Jonathan T Sims, Ching-Yun Chang, Richard E Higgs, Sarah M Engle, Yushi Liu, Sean E Sissons, George H Rodgers, Eric L Simpson, Jonathan I. Silverberg, Seth B Forman, Jonathan M Janes, Stephanie C Colvin, and Emma Guttman-Yassky
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States., Wendy Smith Begolka, Raj Chovatiya, Isabelle J Thibau, and Jonathan I. Silverberg